NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2029-12-01
Target enrollment:
Participant gender:
Summary
This study aims to examine the efficacy of the combination of neoadjuvant chemoradiotherapy and perioperative PD-1 inhibitor in patients with locally advanced esophageal squamous cell cancer and explore the predictive biomarkers for this regimen.